help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ASTON, C.
Right arrow Articles by REIBMAN, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ASTON, C.
Right arrow Articles by REIBMAN, J.

Am. J. Respir. Crit. Care Med., Volume 157, Number 6, June 1998, 1943-1950

Early Inhibition of Mycobacterial Growth by Human Alveolar Macrophages is not Due to Nitric Oxide

CHRISTOPHER ASTON, WILLIAM N. ROM, ANITA T. TALBOT, and JOAN REIBMAN

Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Chemistry, New York University Medical Center, New York, New York

Phagocytic cells provide the first line of defense against mycobacteria. We examined the relative mycobacteriostatic contributions of normal human alveolar macrophages (HAM), peripheral blood monocytes (PBM), and polymorphonuclear leukocytes (PMN) in the early time period after infection with mycobacteria (48 h). Cells were infected with Mycobacterium bovis (BCG) or M. tuberculosis H37Ra and their ability to inhibit growth was determined by mycobacterial incorporation of [3H]uracil. HAM inhibited the growth of both mycobacteria (44.2 ± 7.9 and 37.6 ± 10.5% inhibition, respectively). Two populations of HAM donors were subsequently defined: inhibitors and noninhibitors. The ability to inhibit growth of H37Ra correlated with that of BCG. In contrast to HAM, PBM and PMN did not inhibit mycobacterial growth. Because nitric oxide (NO) has been proposed to mediate growth inhibition in murine models, we examined whether NO was responsible for the early growth inhibition of mycobacteria by HAM. As expected, in murine peritoneal macrophages (MPM) IFN-gamma (2,500 U/ml) enhanced growth inhibition of BCG; the effect was abolished by the nitric oxide synthase (NOS) inhibitor NMMA. In contrast, IFN-gamma failed to enhance growth inhibition by HAM or PBM and NMMA had no effect. MPM expressed inducible nitric oxide synthase (NOS2) mRNA in response to LPS and IFN-gamma and produced NO. Neither NOS2 mRNA nor NO could be detected in HAM stimulated with LPS and IFN-gamma or mycobacteria. These data demonstrate that HAM, but not PBM or PMN, have NO-independent mycobacteriostatic activity in the early time period after infection with mycobacteria.




This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
J. T. Giles and J. M. Bathon
Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases
J Intensive Care Med, November 1, 2004; 19(6): 320 - 334.
[Abstract] [PDF]

Home page
 Infect. Immun.Home page
K. B. Majorov, I. V. Lyadova, T. K. Kondratieva, E. B. Eruslanov, E. I. Rubakova, M. O. Orlova, V. V. Mischenko, and A. S. Apt
Different Innate Ability of I/St and A/Sn Mice To Combat Virulent Mycobacterium tuberculosis: Phenotypes Expressed in Lung and Extrapulmonary Macrophages
Infect. Immun., February 1, 2003; 71(2): 697 - 707.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. O. Kisich, M. Higgins, G. Diamond, and L. Heifets
Tumor Necrosis Factor Alpha Stimulates Killing of Mycobacterium tuberculosis by Human Neutrophils
Infect. Immun., August 1, 2002; 70(8): 4591 - 4599.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. D. Chan, J. Chan, and N. W. Schluger
What is the Role of Nitric Oxide in Murine and Human Host Defense against Tuberculosis? . Current Knowledge
Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 606 - 612.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Boechat, F. Bouchonnet, M. Bonay, A. Grodet, V. Pelicic, B. Gicquel, and A. J. Hance
Culture at High Density Improves the Ability of Human Macrophages to Control Mycobacterial Growth
J. Immunol., May 15, 2001; 166(10): 6203 - 6211.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. D. Chan, K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. H. Riches
Induction of Inducible Nitric Oxide Synthase-NO{middle dot} by Lipoarabinomannan of Mycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-{kappa}B Signaling Pathways
Infect. Immun., April 1, 2001; 69(4): 2001 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H.-P. KUO, C.-H. WANG, K.-S. HUANG, H.-C. LIN, C.-T. YU, C.-Y. LIU, and L.-C. LU
Nitric Oxide Modulates Interleukin-1beta and Tumor Necrosis Factor-alpha Synthesis by Alveolar Macrophages in Pulmonary Tuberculosis
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 192 - 199.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. V. Pechkovsky, G. Zissel, T. Goldmann, M. Einhaus, C. Taube, H. Magnussen, M. Schlaak, and J. Muller-Quernheim
Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II
Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L684 - L692.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  ATS Clinical Skills Tests